Dr. Reddy's Laboratories (RDY) launched single-dose vials of Sugammadex injection in concentrations of 200mg/2mL and 500mg/5mL in the US, the company said Tuesday.
The Sugammadex injection is a generic equivalent of Bridion and is indicated to reverse neuromuscular blockade caused by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged two years and older undergoing surgery, Dr. Reddy's said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments